Fisher & Paykel MyAIRVO 2

The respiratory system is a highly balanced mechanism reliant on humidity, and there are significant clinical benefits for patients who use temperature and humidity in any assisted breathing device. The F&P myAIRVO 2 is the in-home version of the AIRVO used in hospitals, designed to mimic the natural physiological balance in the airway by providing high flow humidification to the respiratory tract, including for patients who have had the upper airway bypassed. Humidification supports the body in three key ways: it assists the natural defence mechanisms in the airway, promotes efficient gas exchange and ventilation, and increases comfort and tolerance to treatment. The myAIRVO 2 delivers up to 37 degrees Celsius and 100% relative humidity simultaneously, creating the optimum environment needed for the body to effectively clear secretions from the lungs while re-hydrating the airway at the same time. Its High Flow component helps reduce the strain of breathing and ensures maximum clearance ability when delivering humidified air, which is particularly important for patients suffering from disorders such as respiratory failure, asthma, COPD, pneumonia, or those using supplemental oxygen. This device can be a genuine game changer for patients suffering from any type of respiratory condition or who need supplemental oxygen, including those living with COPD, cystic fibrosis, bronchiectasis, pulmonary fibrosis, asthma, asbestosis, and lung cancer, from children through to adults. Delivered through an Optiflow™ nasal cannula, the myAIRVO 2 combines an advanced humidity algorithm, a uniquely designed air pathway, and the two-spiral AirSpiral™ tube, which produces up to 93% less condensate than previous tube designs, to accurately and comfortably deliver humidified high flows from 2-60 L/min to chronic respiratory patients at home or in long-term care facilities.

Key Features

• Delivers up to 37°C and 100% relative humidity simultaneously
• Advanced humidity algorithm with intelligent controls at 37, 34, or 31°C
• Uniquely designed air pathway to thoroughly condition the air/oxygen mix
• AirSpiral™ two-spiral tube design for up to 93% less condensate
• Delivered via an Optiflow™ nasal cannula interface
• High flow delivery from 2-60 L/min
• Suitable for home use or long-term care facilities
• Supports patients with an upper airway bypass
• Helps relieve shortness of breath, dry irritable cough, and difficulty clearing secretions
• May help reduce frequent chest infections and hospital re-admissions

Specifications

• Product type: Humidified high flow therapy system
• Model: F&P myAIRVO 2
• Flow range: 2-60 L/min
• Maximum humidity: Up to 100% relative humidity
• Temperature settings: 37°C, 34°C, or 31°C
• Tube type: AirSpiral™ two-spiral design
• Interface: Optiflow™ nasal cannula
• Suitable for: Home use and long-term care facilities
• Patient suitability: Children to adults, including patients with an upper airway bypass